Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels

Overview of attention for article published in JAMA Network Open, November 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 9 news outlets
blogs: 1 blog

twitter: 13 X users
facebook: 1 Facebook page

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 14 X posts from 13 X users, with an upper bound of 1,257,781 followers.

Benefits of adjuvant docetaxel in certain groups of prostate cancer patients. #prostatecancer, #docetaxel https://t.co/Vv1ONYv7lI https://t.co/N4cOqn0KU2

A new study from @BrighamWomens researchers found docetaxel use is associated with significant reduction in prostate cancer death in a group with poor prospect of recovery. Their findings are published in @JAMANetworkOpen. Read more: https://t.co/6ASwz…

* https://t.co/8dk5UW495H

#Docetaxel

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.